期刊文献+

青蒿琥酯逆转多发性骨髓瘤细胞株多药耐药的实验研究 被引量:5

Study on artesunate in reversing MDR of multiple myeloma cell lines
下载PDF
导出
摘要 目的建立小鼠骨髓瘤耐阿霉素(ADM)细胞系SP2/0/ADM,研究青蒿琥酯(ART)对其的影响。方法 ADM低浓度加量持续诱导法建立耐药细胞株;罗丹明123(Rh123)排出实验观察SP2/0/ADM细胞对药物外排情况;采用四甲基偶氮唑蓝(MTT)实验分析SP2/0/ADM细胞株耐药谱和ART对SP2/0/ADM细胞的增殖抑制作用及耐药逆转作用;通过Western blot法检测10μg/ml ART作用24、48、72、96 h后,SP2/0/ADM细胞P-糖蛋白(P-gp)表达变化。结果MTT实验结果显示,SP2/0/ADM细胞不但对ADM产生了耐药性[耐药指数(RI)为22.6],对米托蒽醌、足叶已苷和甲氨蝶呤也产生了不同程度交叉耐药,其RI分别为4.1、2.8和5.3。Rh123排出实验结果显示SP2/0/ADM细胞荧光强度低,而SP2/0细胞中荧光强度高。随ART浓度增加,对SP2/0/ADM细胞增殖抑制作用增强,呈剂量依赖性(P<0.05),其20%抑制浓度(IC20)约为0.3μg/ml。选此浓度进行耐药逆转实验,结果显示ART可增强ADM对SP2/0/ADM细胞的毒性作用,其半数药物抑制浓度(IC50)由17.81μg/ml降至4.26μg/ml,耐药逆转倍数为4.15倍(P<0.05)。随ART作用时间延长,SP2/0/ADM细胞P-gp蛋白表达水平呈下降趋势。与对照组(6 568.25±156.93)比较,ART作用24、48、72、96 h组P-gp蛋白灰度值分别为(4 459.12±297.13)、(4 218.35±153.21)、(3 558.52±241.38)、(3 024.85±157.33),差异有统计学意义(P<0.05)。结论SP2/0/ADM细胞株是成功的骨髓瘤耐药细胞株;ART能逆转SP2/0/ADM细胞对ADM耐药;ART抑制P-gp蛋白表达是其重要作用机制。 Objective To establish the myeloma cell line SP2/0/ADM,which is resistant to adriamycin(ADM),and study the effect of artesunate(ART) on them.Methods The myeloma cell line SP2/0/ADM resistant to ADM was established in vitro by exposing SP2/0 parent cells to increasing concentrations of ADM.The drug discharge capacity of SP2/0/ADM cells was assessed by the fluorescent dye rhodamine 123 efflux experiment.By MTT assay,resistance spectrum of SP2/0 /ADM cells was analyzed,and inhibiting proliferation and reversing multidrug resistance effect of ART on SP2/0/ADM cells were detected.Western blot was used to detect the expression of P-glycoprotein(P-gp) after 10 μg/ml ART treatment for 24 hours,48 hours,72 hours and 96 hours.Results SP2/0/ADM cells developed drug-resistance not only to ADM but also to mitoxantrone,etoposide and methotrexate.The resistance index was 22.6 for ADM,4.1 for mitoxantrone,2.8 for etoposide and 5.3 for methotrexate respectively.The fluorescent intensity of SP2/0/ADM cells was weaker than that in SP2/0 cells in the fluorescent dye rhodamine 123 efflux experiment.ART inhibited the proliferation of SP2/0/ADM cells in dose-dependent manners(P0.05).Since IC20 value was approximately 0.3 μg/ml,resistance reversal experiments of 0.3 μg/ml ART on SP2/0/ADM cells were conducted.The IC50 values of ADM were 17.81 μg/ml without ART and 4.26 μg/ml with ART treatment,and the reversal index was 4.15(P0.05).The expression of P-gp protein in SP2/0/ADM cells decreased gradually with the prolonged duration of ART.The gray value was 6 568.25±156.93 in cells without ART treatment,4 459.12±297.13(P=0.042) in cells treated with ART for 24 hours,4 218.35±153.21(P=0.039) for 48 hours,3 558.52±241.38(P=0.029) for 72 hours and 3 024.85±157.33(P=0.024)for 96 hours,respectively.The change in each group was statistically significant after ART treatment(P0.05).Conclusion SP2/0/ADM cell line is a successful multidrug resistance cell line;ART could reverse the resistance of SP2/0/ADM cells to ADM by inhibiting the expression of P-gp protein.
出处 《安徽医科大学学报》 CAS 北大核心 2013年第9期1075-1078,共4页 Acta Universitatis Medicinalis Anhui
基金 国家自然科学基金地区科学基金项目(编号:30960364)
关键词 青蒿琥酯 骨髓瘤 耐药 阿霉素 artesunate myeloma drug resistance adriamycin
  • 相关文献

参考文献9

  • 1Wesolowska O. Interaction of phenothiazines, stilbenes and fla- vonoids with multidrug resistance-associated transporters, P-glyco- protein and MRPl [J]. Acta Biochim Pol, 2011,58 (d) :433 - 48.
  • 2孔一帆,李俊,黄成,马陶陶,陈昭琳.基于MDCK的葛根素跨膜转运机制的研究[J].安徽医科大学学报,2012,47(12):1418-1422. 被引量:6
  • 3Chen H, Shi L, Yang X, et al. Artesunate inhibiting angiogenesis induced by human myeloma RPMI8226 cells[ J ]. Int J Hematol, 2010,92(4) :587 -97.
  • 4Sedlarikova L, Kubiczkova L, Sevcikova S, et al. Mechanism of immuanmodulatory drugs in muhiple myeloma [ J ]. Leuk Res, 2012,36(10) :1218 -24.
  • 5袁忠,吴玉霞.益肾健脾化瘀泄浊解毒法治疗多发性骨髓瘤肾功能不全[J].中国实验方剂学杂志,2011,17(14):279-281. 被引量:4
  • 6Uchiyama-kokubu N, Walanabe T. Establishment and character- ization of adriamycin-resistant human colorectal adenocarcinoma HCT-15 cell lines with multidrug resistance [ J ]. AnticancerDrugs, 2001,12(9) :769 -79.
  • 7Rossi J F. Chemoresistance and multiple myeloma: from biological to clinical aspects[ J]. Stem Cells Dayt, 1995,13 (Suppl 2) :64 -71.
  • 8Chiva-Blanch G, Gim6nez-Bonafe P, Llaud6 I, et al. Different storing and processing conditions of human lymphocytes do not al- ter P-glycoprotein rhodamine 123 efflux[ J]. J Pharm Pharm Sci, 2009,12(3) :357 -66.
  • 9Callender D M, Hsue G. Artesunate: investigational drug for the treatment of severe faleiparum malaria in Hawaii[ J]. Hawaii Med J, 2011,70(4) :77 -9.

二级参考文献10

  • 1崔升淼,赵春顺,何仲贵.葛根素在Caco-2细胞模型中的吸收特性[J].中草药,2007,38(6):836-839. 被引量:9
  • 2Bohets H, Annaert P,Mannens G, et al. Strategies for absorptionscreening in drug discovery and development[ J]. Cuit Top MedChem, 2001’ 1(5) : 367 -83.
  • 3Annette B, Sibylle H, Kayoshi S,et al. Cell cultures as tools inBiopharmacy [J]. PharmSci, 2000,11(2) ; 51 -60.
  • 4Rothen-Rutishauser B,Kramer S D, Braun A, et al. MDCK cellcultures as an epithelial in vitro model : Cytoskeleton and tightjunction as indicators forthe definition of age-related stages by con-focal microscopy [ J ]. Pharm Res, 1998 , 15(7) : 964 -71.
  • 5Yao X J, Yin J A, Xia Y F, et al. Puerarin exerts antipyreticeffects on lipopolysaccharide-induced fever in rats involving inhibi-tion of pyrogen production from macrophages [ J ]. J Ethnopharma-coi, 2012,141(1): 322-30.
  • 6Cho M J, Thompson D P, Cramer C T,et al. The Madin darbycanine Kidney ( MDCK) epithelial cell monolayer as a model cel-lular transport barrier[J]. Pharm Res, 1989,6(1): 71 -7.
  • 7Volpe D A. Variability in Caco-2 and MDCK cell-based intestinalpermeability assays[ J]. J Pharm Sci, 2008,97(2) : 712 - 25.
  • 8陈媚,葛建丹,宋必卫.有机阴离子转运蛋白介导绿原酸肾小管分泌[J].浙江工业大学学报,2010,9(3):322-325. 被引量:2
  • 9叶丽红,周红光,吴勉华.多发性骨髓瘤骨损的中医证治探讨[J].中国中医药信息杂志,2003,10(8):73-73. 被引量:19
  • 10沈卫章,张凤春,田春艳,徐文,姜玉珍,王秀丽,王春红.38例合并肾功能衰竭的多发性骨髓瘤临床分析[J].中华血液学杂志,2003,24(10):540-541. 被引量:4

共引文献8

同被引文献70

引证文献5

二级引证文献24

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部